CD226 and type 1 diabetes mellitus: Subsequently, we observed that in vitro inhibition of CD226 in PBMCs from T1D donors led to a reduction in the production of pro-inflammatory cytokines by B cells (Fig. 2e) These results suggest that the activation and pro-inflammatory functions of CD226+ B cells may aggravate T1D.